CATALYST BIOSCIENCES INC (CBIO) 0.295 -0.01 (-2.99%)

0.295 -0.01 (-2.99%)

US14888D2080 - Common Stock - After market: 0.3 +0.01 (+1.69%)

Analysts have set a mean price target of 16.32. This target is 5432.2% above the current price.

CBIO was analyzed by 9 analysts. The buy percentage consensus is at 78. So analysts seem to be have mildly positive about CBIO.

In the previous month the buy percentage consensus was at a similar level.

CBIO was analyzed by 9 analysts. More opinions would make the average more meaningful.

Price

Low

Median

Mean

High

0.30

16.16

16.32

16.80

5,377.97%

5,432.20%

5,594.92%

Date	Firm	Action	Rating
2021-11-15	Raymond James	Downgrade	Outperform -> Market Perform
2021-08-06	Raymond James	Maintains	Outperform
2021-04-29	Raymond James	Maintains	Outperform
2021-02-10	Piper Sandler	Initiate	Overweight

Find the competitors with the best analyst ratings on the USA